Vimarsana.com

Latest Breaking News On - Mirum pharmaceuticals company profile - Page 1 : vimarsana.com

836,302 Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Bought by First Turn Management LLC

836,302 Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Bought by First Turn Management LLC
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Arizona
United-states
Texas
China
Stifel-nicolaus
Peter-radovich
Eric-bjerkholt
Nasdaq
Mirum-pharmaceuticals-inc
News-ratings-for-mirum-pharmaceuticals-daily
Securities-exchange-commission
Cantor-fitzgerald

Cantor Fitzgerald Reaffirms "Overweight" Rating for Mirum Pharmaceuticals (NASDAQ:MIRM)

Cantor Fitzgerald Reaffirms "Overweight" Rating for Mirum Pharmaceuticals (NASDAQ:MIRM)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states
Peter-radovich
Stifel-nicolaus
Eric-bjerkholt
Mirum-pharmaceuticals
Mirum-pharmaceuticals-stock-performance
Eventide-asset-management
News-ratings-for-mirum-pharmaceuticals-daily
Nasdaq
Cantor-fitzgerald
Analyst-recommendations-for-mirum-pharmaceuticals
Mirum-pharmaceuticals-inc

Citigroup Raises Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $38.00

Citigroup Raises Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $38.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
China
Eric-bjerkholt
Stifel-nicolaus
Peter-radovich
Mirae-asset-global-investments-co
Mirum-pharmaceuticals-inc
News-ratings-for-mirum-pharmaceuticals-daily
Cantor-fitzgerald
William-blair-investment-management
Analyst-recommendations-for-mirum-pharmaceuticals
Mirum-pharmaceuticals-stock-down

Morgan Stanley Trims Mirum Pharmaceuticals (NASDAQ:MIRM) Target Price to $53.00

Morgan Stanley Trims Mirum Pharmaceuticals (NASDAQ:MIRM) Target Price to $53.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Los-angeles
California
New-york
China
Switzerland
Swiss
Peter-radovich
Eric-bjerkholt
Insider-activity-at-mirum-pharmaceuticals
Morgan-stanley
Securities-exchange-commission

Cantor Fitzgerald Reaffirms Overweight Rating for Mirum Pharmaceuticals (NASDAQ:MIRM)

Cantor Fitzgerald Reaffirms Overweight Rating for Mirum Pharmaceuticals (NASDAQ:MIRM)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
United-states
Stifel-nicolaus
Eric-bjerkholt
Peter-radovich
Mirum-pharmaceuticals
Mirum-pharmaceuticals-inc
Securities-exchange-commission
Mirum-pharmaceuticals-price-performance
Quest-partners
Institutional-investors-weigh-in-on-mirum-pharmaceuticals
Mirum-pharmaceuticals-company-profile

vimarsana © 2020. All Rights Reserved.